title: TB vaccines in clinical development.
abstract: The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 - 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future directions for this critical effort. This paper summarizes the sessions on TB Vaccines in Clinical Development, and Clinical Research: Data and Findings. Summaries of all sessions from the 4th Global Forum are compiled in a special supplement of Tuberculosis. [August 2016, Vol 99, Supp S1, S1-S30].
authors.affiliation: Aeras, Rockville, MD, USA. Electronic address: aginsberg@aeras.org.
authors.forename: Ann M
authors.initials: AM
authors.lastname: Ginsberg
authors.affiliation: Statens Serum Institut, Copenhagen, Denmark.
authors.forename: Morten
authors.initials: M
authors.lastname: Ruhwald
authors.affiliation: South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
authors.forename: Helen
authors.initials: H
authors.lastname: Mearns
authors.affiliation: Jenner Institute, University of Oxford, Oxford, UK.
authors.forename: Helen
authors.initials: H
authors.lastname: McShane
mesh_terms: D000336:Aerosols; D000818:Animals; D001500:BCG Vaccine / Q000009:adverse effects / Q000276:immunology / Q000493:pharmacokinetics; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D016503:Drug Delivery Systems; D055808:Drug Discovery; D006168:Guinea Pigs; D006801:Humans; D007111:Immunity, Cellular; D007117:Immunization, Secondary; D007156:Immunologic Memory / Q000276:immunology; D014376:Tuberculosis / Q000517:prevention & control*; D032581:Tuberculosis Vaccines / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology*; D014613:Vaccines, Attenuated / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology
chemical_list: D000336:Aerosols; D001500:BCG Vaccine; D032581:Tuberculosis Vaccines; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic
keywords: Clinical trial; Immunogenicity; Safety; TB vaccine